Roquette Freres   Report issue

For profit Phase 3
Founded: Lestrem France (1933)
Status: No NME R&D (1933)

Organization Overview

First Clinical Trial
2006
NCT01044680
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Roquette Freres

Active Ingredients

Drugs in Phase 3 Trials (1)

cellulose (4 trials)

Drugs in Other Trials (7)

apple (1 trial)

glucose (2 trials)

hydrolyzed casein (1 trial)

maltodextrin (2 trials)

pea (3 trials)

turmeric (1 trial)

whey protein (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Metabolic Syndrome (Phase 3)

Overweight (Phase 3)

Syndrome (Phase 3)

Weight Loss (Phase 1)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 10
  • # of Trial APIs: 8